ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Vaccine Adjuvants Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-16A8759
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Human Vaccine Adjuvants Market Insights and Forecast to 2028
BUY CHAPTERS

Global Human Vaccine Adjuvants Market Research Report 2024

Code: QYRE-Auto-16A8759
Report
February 2024
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GSK
CSL Limited
SEPPIC
CRODA
Sanofi
Zhifei Biological
ESCON
Huanuotai Biological
Rico Bio

Human Vaccine Adjuvants Market

The global Human Vaccine Adjuvants market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In China, the key players of human vaccine adjuvants include GSK, CSL Limited, Croda, SEPPIC, Sanofi, Zhifei Biological, etc.
This report aims to provide a comprehensive presentation of the global market for Human Vaccine Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Vaccine Adjuvants.

Report Scope

The Human Vaccine Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Vaccine Adjuvants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Vaccine Adjuvants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Human Vaccine Adjuvants Market Report

Report Metric Details
Report Name Human Vaccine Adjuvants Market
Segment by Type
  • Aluminium Salt Adjuvant
  • Oil Emulsion Adjuvant
  • Others
Segment by Application
  • Commercial
  • Research
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GSK, CSL Limited, Croda, SEPPIC, Sanofi, Zhifei Biological, Escon, Huanuotai Biological, Rico Bio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Vaccine Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Vaccine Adjuvants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Human Vaccine Adjuvants Market report?

Ans: The main players in the Human Vaccine Adjuvants Market are GSK, CSL Limited, Croda, SEPPIC, Sanofi, Zhifei Biological, Escon, Huanuotai Biological, Rico Bio

What are the Application segmentation covered in the Human Vaccine Adjuvants Market report?

Ans: The Applications covered in the Human Vaccine Adjuvants Market report are Commercial, Research

What are the Type segmentation covered in the Human Vaccine Adjuvants Market report?

Ans: The Types covered in the Human Vaccine Adjuvants Market report are Aluminium Salt Adjuvant, Oil Emulsion Adjuvant, Others

1 Human Vaccine Adjuvants Market Overview
1.1 Product Overview and Scope of Human Vaccine Adjuvants
1.2 Human Vaccine Adjuvants Segment by Type
1.2.1 Global Human Vaccine Adjuvants Market Value Comparison by Type (2024-2030)
1.2.2 Aluminium Salt Adjuvant
1.2.3 Oil Emulsion Adjuvant
1.2.4 Others
1.3 Human Vaccine Adjuvants Segment by Application
1.3.1 Global Human Vaccine Adjuvants Market Value by Application: (2024-2030)
1.3.2 Commercial
1.3.3 Research
1.4 Global Human Vaccine Adjuvants Market Size Estimates and Forecasts
1.4.1 Global Human Vaccine Adjuvants Revenue 2019-2030
1.4.2 Global Human Vaccine Adjuvants Sales 2019-2030
1.4.3 Global Human Vaccine Adjuvants Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Vaccine Adjuvants Market Competition by Manufacturers
2.1 Global Human Vaccine Adjuvants Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Vaccine Adjuvants Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Vaccine Adjuvants Average Price by Manufacturers (2019-2024)
2.4 Global Human Vaccine Adjuvants Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Vaccine Adjuvants, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Vaccine Adjuvants, Product Type & Application
2.7 Human Vaccine Adjuvants Market Competitive Situation and Trends
2.7.1 Human Vaccine Adjuvants Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Vaccine Adjuvants Players Market Share by Revenue
2.7.3 Global Human Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Vaccine Adjuvants Retrospective Market Scenario by Region
3.1 Global Human Vaccine Adjuvants Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Vaccine Adjuvants Global Human Vaccine Adjuvants Sales by Region: 2019-2030
3.2.1 Global Human Vaccine Adjuvants Sales by Region: 2019-2024
3.2.2 Global Human Vaccine Adjuvants Sales by Region: 2025-2030
3.3 Global Human Vaccine Adjuvants Global Human Vaccine Adjuvants Revenue by Region: 2019-2030
3.3.1 Global Human Vaccine Adjuvants Revenue by Region: 2019-2024
3.3.2 Global Human Vaccine Adjuvants Revenue by Region: 2025-2030
3.4 North America Human Vaccine Adjuvants Market Facts & Figures by Country
3.4.1 North America Human Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Vaccine Adjuvants Sales by Country (2019-2030)
3.4.3 North America Human Vaccine Adjuvants Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Vaccine Adjuvants Market Facts & Figures by Country
3.5.1 Europe Human Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Vaccine Adjuvants Sales by Country (2019-2030)
3.5.3 Europe Human Vaccine Adjuvants Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Vaccine Adjuvants Market Facts & Figures by Country
3.6.1 Asia Pacific Human Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Vaccine Adjuvants Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Vaccine Adjuvants Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Human Vaccine Adjuvants Market Facts & Figures by Country
3.7.1 Latin America Human Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Vaccine Adjuvants Sales by Country (2019-2030)
3.7.3 Latin America Human Vaccine Adjuvants Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Vaccine Adjuvants Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Vaccine Adjuvants Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Vaccine Adjuvants Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Vaccine Adjuvants Sales by Type (2019-2030)
4.1.1 Global Human Vaccine Adjuvants Sales by Type (2019-2024)
4.1.2 Global Human Vaccine Adjuvants Sales by Type (2025-2030)
4.1.3 Global Human Vaccine Adjuvants Sales Market Share by Type (2019-2030)
4.2 Global Human Vaccine Adjuvants Revenue by Type (2019-2030)
4.2.1 Global Human Vaccine Adjuvants Revenue by Type (2019-2024)
4.2.2 Global Human Vaccine Adjuvants Revenue by Type (2025-2030)
4.2.3 Global Human Vaccine Adjuvants Revenue Market Share by Type (2019-2030)
4.3 Global Human Vaccine Adjuvants Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Vaccine Adjuvants Sales by Application (2019-2030)
5.1.1 Global Human Vaccine Adjuvants Sales by Application (2019-2024)
5.1.2 Global Human Vaccine Adjuvants Sales by Application (2025-2030)
5.1.3 Global Human Vaccine Adjuvants Sales Market Share by Application (2019-2030)
5.2 Global Human Vaccine Adjuvants Revenue by Application (2019-2030)
5.2.1 Global Human Vaccine Adjuvants Revenue by Application (2019-2024)
5.2.2 Global Human Vaccine Adjuvants Revenue by Application (2025-2030)
5.2.3 Global Human Vaccine Adjuvants Revenue Market Share by Application (2019-2030)
5.3 Global Human Vaccine Adjuvants Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Human Vaccine Adjuvants Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 CSL Limited
6.2.1 CSL Limited Corporation Information
6.2.2 CSL Limited Description and Business Overview
6.2.3 CSL Limited Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Limited Human Vaccine Adjuvants Product Portfolio
6.2.5 CSL Limited Recent Developments/Updates
6.3 Croda
6.3.1 Croda Corporation Information
6.3.2 Croda Description and Business Overview
6.3.3 Croda Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Croda Human Vaccine Adjuvants Product Portfolio
6.3.5 Croda Recent Developments/Updates
6.4 SEPPIC
6.4.1 SEPPIC Corporation Information
6.4.2 SEPPIC Description and Business Overview
6.4.3 SEPPIC Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.4.4 SEPPIC Human Vaccine Adjuvants Product Portfolio
6.4.5 SEPPIC Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanofi Human Vaccine Adjuvants Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Zhifei Biological
6.6.1 Zhifei Biological Corporation Information
6.6.2 Zhifei Biological Description and Business Overview
6.6.3 Zhifei Biological Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Zhifei Biological Human Vaccine Adjuvants Product Portfolio
6.6.5 Zhifei Biological Recent Developments/Updates
6.7 Escon
6.6.1 Escon Corporation Information
6.6.2 Escon Description and Business Overview
6.6.3 Escon Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Escon Human Vaccine Adjuvants Product Portfolio
6.7.5 Escon Recent Developments/Updates
6.8 Huanuotai Biological
6.8.1 Huanuotai Biological Corporation Information
6.8.2 Huanuotai Biological Description and Business Overview
6.8.3 Huanuotai Biological Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Huanuotai Biological Human Vaccine Adjuvants Product Portfolio
6.8.5 Huanuotai Biological Recent Developments/Updates
6.9 Rico Bio
6.9.1 Rico Bio Corporation Information
6.9.2 Rico Bio Description and Business Overview
6.9.3 Rico Bio Human Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Rico Bio Human Vaccine Adjuvants Product Portfolio
6.9.5 Rico Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Vaccine Adjuvants Industry Chain Analysis
7.2 Human Vaccine Adjuvants Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Vaccine Adjuvants Production Mode & Process
7.4 Human Vaccine Adjuvants Sales and Marketing
7.4.1 Human Vaccine Adjuvants Sales Channels
7.4.2 Human Vaccine Adjuvants Distributors
7.5 Human Vaccine Adjuvants Customers
8 Human Vaccine Adjuvants Market Dynamics
8.1 Human Vaccine Adjuvants Industry Trends
8.2 Human Vaccine Adjuvants Market Drivers
8.3 Human Vaccine Adjuvants Market Challenges
8.4 Human Vaccine Adjuvants Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GSK
CSL Limited
SEPPIC
CRODA
Sanofi
Zhifei Biological
ESCON
Huanuotai Biological
Rico Bio
List of Tables
    Table 1. Global Human Vaccine Adjuvants Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Human Vaccine Adjuvants Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Human Vaccine Adjuvants Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Human Vaccine Adjuvants Sales (Tons) of Key Manufacturers (2019-2024)
    Table 5. Global Human Vaccine Adjuvants Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Human Vaccine Adjuvants Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Human Vaccine Adjuvants Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Human Vaccine Adjuvants Average Price (US$/吨) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Human Vaccine Adjuvants, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Human Vaccine Adjuvants, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Human Vaccine Adjuvants, Product Type & Application
    Table 12. Global Key Manufacturers of Human Vaccine Adjuvants, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Human Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Vaccine Adjuvants as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Human Vaccine Adjuvants Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Human Vaccine Adjuvants Sales by Region (2019-2024) & (Tons)
    Table 18. Global Human Vaccine Adjuvants Sales Market Share by Region (2019-2024)
    Table 19. Global Human Vaccine Adjuvants Sales by Region (2025-2030) & (Tons)
    Table 20. Global Human Vaccine Adjuvants Sales Market Share by Region (2025-2030)
    Table 21. Global Human Vaccine Adjuvants Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Human Vaccine Adjuvants Revenue Market Share by Region (2019-2024)
    Table 23. Global Human Vaccine Adjuvants Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Human Vaccine Adjuvants Revenue Market Share by Region (2025-2030)
    Table 25. North America Human Vaccine Adjuvants Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Human Vaccine Adjuvants Sales by Country (2019-2024) & (Tons)
    Table 27. North America Human Vaccine Adjuvants Sales by Country (2025-2030) & (Tons)
    Table 28. North America Human Vaccine Adjuvants Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Human Vaccine Adjuvants Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Human Vaccine Adjuvants Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Human Vaccine Adjuvants Sales by Country (2019-2024) & (Tons)
    Table 32. Europe Human Vaccine Adjuvants Sales by Country (2025-2030) & (Tons)
    Table 33. Europe Human Vaccine Adjuvants Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Human Vaccine Adjuvants Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Human Vaccine Adjuvants Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Human Vaccine Adjuvants Sales by Region (2019-2024) & (Tons)
    Table 37. Asia Pacific Human Vaccine Adjuvants Sales by Region (2025-2030) & (Tons)
    Table 38. Asia Pacific Human Vaccine Adjuvants Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Human Vaccine Adjuvants Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Human Vaccine Adjuvants Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Human Vaccine Adjuvants Sales by Country (2019-2024) & (Tons)
    Table 42. Latin America Human Vaccine Adjuvants Sales by Country (2025-2030) & (Tons)
    Table 43. Latin America Human Vaccine Adjuvants Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Human Vaccine Adjuvants Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Human Vaccine Adjuvants Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Human Vaccine Adjuvants Sales by Country (2019-2024) & (Tons)
    Table 47. Middle East & Africa Human Vaccine Adjuvants Sales by Country (2025-2030) & (Tons)
    Table 48. Middle East & Africa Human Vaccine Adjuvants Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Human Vaccine Adjuvants Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Human Vaccine Adjuvants Sales (Tons) by Type (2019-2024)
    Table 51. Global Human Vaccine Adjuvants Sales (Tons) by Type (2025-2030)
    Table 52. Global Human Vaccine Adjuvants Sales Market Share by Type (2019-2024)
    Table 53. Global Human Vaccine Adjuvants Sales Market Share by Type (2025-2030)
    Table 54. Global Human Vaccine Adjuvants Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Human Vaccine Adjuvants Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Human Vaccine Adjuvants Revenue Market Share by Type (2019-2024)
    Table 57. Global Human Vaccine Adjuvants Revenue Market Share by Type (2025-2030)
    Table 58. Global Human Vaccine Adjuvants Price (US$/吨) by Type (2019-2024)
    Table 59. Global Human Vaccine Adjuvants Price (US$/吨) by Type (2025-2030)
    Table 60. Global Human Vaccine Adjuvants Sales (Tons) by Application (2019-2024)
    Table 61. Global Human Vaccine Adjuvants Sales (Tons) by Application (2025-2030)
    Table 62. Global Human Vaccine Adjuvants Sales Market Share by Application (2019-2024)
    Table 63. Global Human Vaccine Adjuvants Sales Market Share by Application (2025-2030)
    Table 64. Global Human Vaccine Adjuvants Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Human Vaccine Adjuvants Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Human Vaccine Adjuvants Revenue Market Share by Application (2019-2024)
    Table 67. Global Human Vaccine Adjuvants Revenue Market Share by Application (2025-2030)
    Table 68. Global Human Vaccine Adjuvants Price (US$/吨) by Application (2019-2024)
    Table 69. Global Human Vaccine Adjuvants Price (US$/吨) by Application (2025-2030)
    Table 70. GSK Corporation Information
    Table 71. GSK Description and Business Overview
    Table 72. GSK Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/吨) and Gross Margin (2019-2024)
    Table 73. GSK Human Vaccine Adjuvants Product
    Table 74. GSK Recent Developments/Updates
    Table 75. CSL Limited Corporation Information
    Table 76. CSL Limited Description and Business Overview
    Table 77. CSL Limited Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/吨) and Gross Margin (2019-2024)
    Table 78. CSL Limited Human Vaccine Adjuvants Product
    Table 79. CSL Limited Recent Developments/Updates
    Table 80. Croda Corporation Information
    Table 81. Croda Description and Business Overview
    Table 82. Croda Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/吨) and Gross Margin (2019-2024)
    Table 83. Croda Human Vaccine Adjuvants Product
    Table 84. Croda Recent Developments/Updates
    Table 85. SEPPIC Corporation Information
    Table 86. SEPPIC Description and Business Overview
    Table 87. SEPPIC Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/吨) and Gross Margin (2019-2024)
    Table 88. SEPPIC Human Vaccine Adjuvants Product
    Table 89. SEPPIC Recent Developments/Updates
    Table 90. Sanofi Corporation Information
    Table 91. Sanofi Description and Business Overview
    Table 92. Sanofi Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/吨) and Gross Margin (2019-2024)
    Table 93. Sanofi Human Vaccine Adjuvants Product
    Table 94. Sanofi Recent Developments/Updates
    Table 95. Zhifei Biological Corporation Information
    Table 96. Zhifei Biological Description and Business Overview
    Table 97. Zhifei Biological Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/吨) and Gross Margin (2019-2024)
    Table 98. Zhifei Biological Human Vaccine Adjuvants Product
    Table 99. Zhifei Biological Recent Developments/Updates
    Table 100. Escon Corporation Information
    Table 101. Escon Description and Business Overview
    Table 102. Escon Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/吨) and Gross Margin (2019-2024)
    Table 103. Escon Human Vaccine Adjuvants Product
    Table 104. Escon Recent Developments/Updates
    Table 105. Huanuotai Biological Corporation Information
    Table 106. Huanuotai Biological Description and Business Overview
    Table 107. Huanuotai Biological Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/吨) and Gross Margin (2019-2024)
    Table 108. Huanuotai Biological Human Vaccine Adjuvants Product
    Table 109. Huanuotai Biological Recent Developments/Updates
    Table 110. Rico Bio Corporation Information
    Table 111. Rico Bio Description and Business Overview
    Table 112. Rico Bio Human Vaccine Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/吨) and Gross Margin (2019-2024)
    Table 113. Rico Bio Human Vaccine Adjuvants Product
    Table 114. Rico Bio Recent Developments/Updates
    Table 115. Key Raw Materials Lists
    Table 116. Raw Materials Key Suppliers Lists
    Table 117. Human Vaccine Adjuvants Distributors List
    Table 118. Human Vaccine Adjuvants Customers List
    Table 119. Human Vaccine Adjuvants Market Trends
    Table 120. Human Vaccine Adjuvants Market Drivers
    Table 121. Human Vaccine Adjuvants Market Challenges
    Table 122. Human Vaccine Adjuvants Market Restraints
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Human Vaccine Adjuvants
    Figure 2. Global Human Vaccine Adjuvants Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Human Vaccine Adjuvants Market Share by Type in 2023 & 2030
    Figure 4. Aluminium Salt Adjuvant Product Picture
    Figure 5. Oil Emulsion Adjuvant Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Human Vaccine Adjuvants Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Human Vaccine Adjuvants Market Share by Application in 2023 & 2030
    Figure 9. Commercial
    Figure 10. Research
    Figure 11. Global Human Vaccine Adjuvants Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Human Vaccine Adjuvants Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Human Vaccine Adjuvants Sales (2019-2030) & (Tons)
    Figure 14. Global Human Vaccine Adjuvants Average Price (US$/吨) & (2019-2030)
    Figure 15. Human Vaccine Adjuvants Report Years Considered
    Figure 16. Human Vaccine Adjuvants Sales Share by Manufacturers in 2023
    Figure 17. Global Human Vaccine Adjuvants Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Human Vaccine Adjuvants Players: Market Share by Revenue in 2023
    Figure 19. Human Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Human Vaccine Adjuvants Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Human Vaccine Adjuvants Sales Market Share by Country (2019-2030)
    Figure 22. North America Human Vaccine Adjuvants Revenue Market Share by Country (2019-2030)
    Figure 23. United States Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Europe Human Vaccine Adjuvants Sales Market Share by Country (2019-2030)
    Figure 26. Europe Human Vaccine Adjuvants Revenue Market Share by Country (2019-2030)
    Figure 27. Germany Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. France Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. U.K. Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Italy Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Russia Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Human Vaccine Adjuvants Sales Market Share by Region (2019-2030)
    Figure 33. Asia Pacific Human Vaccine Adjuvants Revenue Market Share by Region (2019-2030)
    Figure 34. China Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Japan Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. South Korea Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. India Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Australia Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. China Taiwan Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Indonesia Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Thailand Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Malaysia Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Latin America Human Vaccine Adjuvants Sales Market Share by Country (2019-2030)
    Figure 44. Latin America Human Vaccine Adjuvants Revenue Market Share by Country (2019-2030)
    Figure 45. Mexico Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Brazil Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Argentina Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Middle East & Africa Human Vaccine Adjuvants Sales Market Share by Country (2019-2030)
    Figure 49. Middle East & Africa Human Vaccine Adjuvants Revenue Market Share by Country (2019-2030)
    Figure 50. Turkey Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Saudi Arabia Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. UAE Human Vaccine Adjuvants Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Global Sales Market Share of Human Vaccine Adjuvants by Type (2019-2030)
    Figure 54. Global Revenue Market Share of Human Vaccine Adjuvants by Type (2019-2030)
    Figure 55. Global Human Vaccine Adjuvants Price (US$/吨) by Type (2019-2030)
    Figure 56. Global Sales Market Share of Human Vaccine Adjuvants by Application (2019-2030)
    Figure 57. Global Revenue Market Share of Human Vaccine Adjuvants by Application (2019-2030)
    Figure 58. Global Human Vaccine Adjuvants Price (US$/吨) by Application (2019-2030)
    Figure 59. Human Vaccine Adjuvants Value Chain
    Figure 60. Human Vaccine Adjuvants Production Process
    Figure 61. Channels of Distribution (Direct Vs Distribution)
    Figure 62. Distributors Profiles
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions